STAT Plus: The little-known bill that made drugs more affordable
drug patents
Drug patents are used, and sometimes abused, as a way to protect pharma profits by limiting competition. From gamesmanship with patent thickets to questionable practices with the FDA Orange Book, STAT covers issues of patients versus profits.
Latest
STAT Plus: How drug patents pave the way to profit
STAT Plus: U.S. Patent Office software mistakes extend patent life for drugs and need to be fixed, researchers say
STAT Plus: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down
STAT Plus: After months of warnings, FTC opens investigation into Teva over ‘improper’ patents
STAT Plus: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace
STAT Plus: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
STAT Plus: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
All Coverage
advertisement
